19 Nov 2023
TAVI durability and potential future solutions - LIVE case
New valves for TAV in TAV and native aortic valve stenosis
Operators:
N. Dumonteil, D. Tchetche
Procedural Analyst:
N. Piazza
Summary
In this session, you will learn more about the potential technical challenges associated with second-time TAVI procedures, and the importance of detailed CT imaging and careful pre-procedural planning. Discover the latest innovations and future direction of this key area of development.
- Live case: An 83-year-old woman with type 2 diabetes, COPD and a history of TF-TAVI with 23mm Lotus edge complicated by PPM, presented a symptomatic severe bioprosthesis valve stenosis with an 18 mm inner diameter and preserved LV function. The operators performed an Evolut FX implantation.
- Recorded case: A 66-year-old woman with diabetes presented a symptomatic severe aortic stenosis. Watch the operators implant a DurAVR system.
Navigate the video by moving your mouse over the chapter icon in the toolbar
Key moments
- 03:47-08:40 - CT analysis
- 21:01-22:19 - Description of the Evolut FX
- 22:22-32:20 - Positioning and deployment of the valve
- 32:22-36:04 - Post dilatation
- 47:11-51:29 - Procedural analysis
- 59:01-01:00:26 - Presentation of the DurAVR valve
- 01:00:45-01:02:55 - Valve deployment
- 01:03:33-01:04:10 - Post dilatation
Keywords: TAVI in TAVI, TAVI, Evolut FX, Post dilatation, DurAVR system, sentinel
Learning Objectives
- To learn more about the potential technical challenges associated with second time TAVI procedures (TAV-in-TAV)
- To understand the importance of detailed CT imaging and careful pre-procedural planning
- To hear about the latest innovations and future direction of this key area of innovation and development
